RTW Biotech Opportunities (LON:RTW) Shares Up 0.9% – Still a Buy?

RTW Biotech Opportunities (LON:RTW)’s stock price shot up 0.9% during mid-day trading on Friday . The company traded as high as GBX 2.23 and last traded at GBX 2.21. 291,903 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 1,074,778 shares. The stock had previously closed at GBX 2.19.

RTW Biotech Opportunities Price Performance

The business has a 50-day moving average of GBX 2.04 and a 200-day moving average of GBX 1.98. The firm has a market cap of £7.19 million, a price-to-earnings ratio of 0.04 and a beta of 0.74.

RTW Biotech Opportunities Company Profile

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.